Atlas Trials

Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)

Clinical trial NCT02676310 · TERMINATED

Trial details

NCT number
NCT02676310
Sponsor
Allergan
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
AlopeciaAlopecia, AndrogeneticBaldness
Start date
2016-03-01
Primary completion
2017-01-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.